Tag: Eli Lilly and Company

Tag Archives: Eli Lilly and Company

18Jul/23

ALZHEIMER’S ASSOCIATION STATEMENT ON DONANEMAB PHASE 3 DATA REPORTED AT AAIC 2023

July 18, 2023ReasearchAAIC, Alzheimer's Association, Alzheimer's disease, Amsterdam, Clinical trial, Donanemab, Eli Lilly, Eli Lilly and Company, Monoclonal antibodies, Netherlandsadmin

The data reported today by Eli Lilly from the TRAILBLAZER-ALZ 2 clinical trial of donanemab in early symptomatic Alzheimer’s disease demonstrate an important advancement in Alzheimer’s research and treatment. The full Phase 3 data was reported at the Alzheimer’s Association International Conference® (AAIC®) 2023, in Amsterdam, Netherlands, and online. The data were simultaneously published in the Journal of the American Medical Association. Continue reading

16Apr/23

This Week in Health News: Top Stories You Need to See

April 16, 2023HealthAlzheimer's Association, Alzheimer's disease, Cognitive disorders, crenezumab, Dementia, Dobbs, Eli Lilly and Company, Health, Learning disabilities, Medicine, Obesity, Parkinson, Psychiatric diagnosis, Psychiatry, Roe, Roe v. Wade, RTT, United States, Wadeadmin

NEW YORK, April 14, 2023 /Health/– Here are some of the top health news stories from this week:

New COVID-19 variant BA.2 spreads rapidly in Europe and the US
US Supreme Court to hear case on abortion rights
WHO reports more than 1 million deaths from COVID-19
New study finds that obesity can increase risk of dementia
Researchers develop new drug that could treat Alzheimer’s disease
Continue reading →